Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia

F1000Research

Volumn 3, Issue , 2014, Pages

  Ankersmit, Hendrik Jan ^a,b   Altmann, Patrick ^a,b   Mildner, Michael ^c   Haider, Thomas ^a,b   Traxler, Denise ^a,b   Beer, Lucian ^a   Ristl, Robin ^a   Golabi, Bahar ^c   Gabriel, Christian ^d   Leutmezer, Fritz ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE FOR MICROELECTRONICS   (Austria)

^c Universitatsklinik fur Dermatologie   (Austria)

^d Red Cross Transfusion Service for Upper Austria   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CELL PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; SECRETOME; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONONUCLEAR CELL; NERVE CELL; NERVE SPROUTING; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROLOGICAL DAMAGE; NEUROPROTECTION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RAT; SCHWANN CELL; SIGNAL TRANSDUCTION; WISTAR RAT;

EID: 84923253388     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.4219.2     Document Type: Article

References (54)

1. Abe K: Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J Cereb Blood Flow Metab. 2000;20(10):1393-1408. 11043902 10.1097/00004647-200010000-00001
2. Ankersmit HJ Hoetzenecker K Dietl W: Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest. 2009;39(6):445-456. 19397690 10.1111/j.1365-2362.2009.02111.x
3. Altmann P Mildner M Haider T: Apoptotic MNC-secretomes in experimental stroke. figshare. 2014. Data Source
4. Assmus B Iwasaki M Schächinger V: Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow. Eur Heart J. 2011;33(15):1911-9. 22173911 10.1093/eurheartj/ehr388
5. Bederson JB Pitts LH Germano SM: Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17(6):1304-1308. 2433817 10.1161/01.STR.17.6.1304
6. Brunner S Engelmann MG Franz WM: Stem cell mobilisation for myocardial repair. Expert Opin Biol Ther. 2008;8(11):1675-1690. 18847304 10.1517/14712598.8.11.1675
7. Chen J Li Y Wang L: Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32(4):1005-1011. 11283404 10.1161/01.STR.32.4.1005
8. Crigler L Robey RC Asawachaicharn A: Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol. 2006;198(1):54-64. 16336965 10.1016/j.expneurol.2005.10.029
9. Di Santo S Yang Z Wyler von Ballmoos M: Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One. 2009;4(5):e5643. 19479066 10.1371/journal.pone.0005643 2682571
10. Fadok VA Bratton DL Henson PM: Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest. 2001;108(7):957-962. 11581295 10.1172/JCI14122 200959
11. Ferrer I Krupinski J Goutan E: Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol. 2001;101(3):229-38. 11307622 10.1007/s004010000268
12. Fisher M Feuerstein G Howells DW: Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40(1):2244-2250. 19246690 10.1161/STROKEAHA.108.541128 2888275
13. Fonarow GC Smith EE Saver JL: Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123(7):750-758. 21311083 10.1161/CIRCULATIONAHA.110.974675
14. Gauvin G Nims R: Gamma-irradiation of serum for the inactivation of adventitious contaminants. PDA J Pharm Sci Technol. 2010;64(5):432-435. 21502047
15. Giaume C Koulakoff A Roux L: Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat Rev Neurosci. 2010;11(2):87-99. 20087359 10.1038/nrn2757
16. Gnecchi M Danieli P Cervio E: Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol. 2012;57(1):48-55. 22521741 10.1016/j.vph.2012.04.002
17. Hoetzenecker K Assinger A Lichtenauer M: Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Basic Res Cardiol. 2012;107(5):1-14. 22899170 10.1007/s00395-012-0292-2 3442164
18. Hoetzenecker K Zimmermann M Hoetzenecker W: Mononuclear cell secretome protects from experimental autoimmune myocarditis. Eur Heart J. 2013. 23321350 10.1093/eurheartj/ehs459
19. Iadecola C Anrather J: Stroke research at a crossroad: asking the brain for directions. Nat Neurosci. 2011;14(11):1363-1368. 22030546 10.1038/nn.2953 3633153
20. Jayaraman P Nathan P Vasanthan P: Stem cells conditioned medium: a new approach to skin wound healing management. Cell Biol Int. 2013;37(10):1122-1128. 23716460 10.1002/cbin.10138
21. Jensen BC Patterson C: Heart factory or fiction?: cardiac progenitor cells and regeneration. Circulation. 2013;128(20):2181-2. 24141257 10.1161/CIRCULATIONAHA.113.006262
22. Jiang Y Wei N Lu T: Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience. 2011;172:398-405. 21034794 10.1016/j.neuroscience.2010.10.054
23. Joyce N Annett G Wirthlin L: Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med. 2010;5(6):933-946. 21082892 10.2217/rme.10.72 3017479
24. Korf-Klingebiel M Kempf T Sauer T: Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J. 2008;29(23):2851-8. 18953051 10.1093/eurheartj/ehn456
25. Lagasse E Connors H Al-Dhalimy M: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6(11):1229-1234. 11062533 10.1038/81326
26. Lambrecht B Mohr H Knüver-Hopf J: Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang. 1991;60(4):207-213. 1656610 10.1111/j.1423-0410.1991.tb00907.x
27. Lemmens R Steinberg GK: Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol. 2013;26(6):617-25. 24136128 10.1097/WCO.0000000000000023
28. Lichtenauer M Mildner M Baumgartner A: Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol. 2011a;106(4):645-655. 21416207 10.1007/s00395-011-0173-0 3105227
29. Lichtenauer M Mildner M Hoetzenecker K: Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res Cardiol. 2011b;106(6):1283-1297. 21952733 10.1007/s00395-011-0224-6 3228946
30. Longa EZ Weinstein PR Carlson S: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84-91. 2643202 10.1161/01.STR.20.1.84
31. Mildner M Hacker S Haider T: Secretome of peripheral blood mononuclear cells enhances wound healing. PLoS One. 2013;8(3):e60103. 23533667 10.1371/journal.pone.0060103 3606336
32. Moskowitz MA: Brain protection: maybe yes maybe no. Stroke. 2010;41(10 Suppl):S85-S86. 20876513 10.1161/STROKEAHA.110.598458
33. Nedelmann M Wilhelm-Schwenkmezger T Alessandri B: Cerebral embolic ischemia in rats: correlation of stroke severity and functional deficit as important outcome parameter. Brain Res. 2007;1130(1):188-196. 17157825 10.1016/j.brainres.2006.10.087
34. Nims RW Gauvin G Plavsic M: Gamma irradiation of animal sera for inactivation of viruses and mollicutes--a review. Biologicals. 2011;39(6):370-377. 21871817 10.1016/j.biologicals.2011.05.003
35. Nold-Petry CA Rudloff I Baumer Y: IL-32 promotes angiogenesis. J Immunol. 2010;15(2):589-602. 24337385 10.4049/jimmunol.1202802 4007307
36. Ploughman M Windle V MacLellan CL: Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke. 2009;40(4):1490-1495. 19164786 10.1161/STROKEAHA.108.531806
37. Qi D Liu H Niu J: Heat shock protein 72 inhibits c-Jun N-terminal kinase 3 signaling pathway via Akt1 during cerebral ischemia. J Neurol Sci. 2012;317(1-2):123-129. 22386689 10.1016/j.jns.2012.02.011
38. Richard S: Animal research: the need for a middle ground, Let's promote the three Rs of animal research: replacement, reduction, and refinement. BMJ. 2001;322(7281):248-9. 11157509 10.1136/bmj.322.7281.248 1119509
39. Roger VL Go AS Lloyd-Jones DM: Executive summary: heart disease and stroke statistics--2012 Update: a report from the American Heart Association. Circulation. 2012;125(1):188-197. 22215894 10.1161/CIR.0b013e3182456d46
40. Roux PP Blenis J: ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68(2):320-344. 15187187 10.1128/MMBR.68.2.320-344.2004 419926
41. Saas P Gaugler B Perruche S: Intravenous apoptotic cell infusion as a cell-based therapy toward improving hematopoietic cell transplantation outcome. Ann N Y Acad Sci. 2010;1209:118-126. 20958324 10.1111/j.1749-6632.2010.05741.x
42. Schäbitz WR Steigleder T Cooper-Kuhn CM: Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke. 2007;38(7):2165-2172. 17510456 10.1161/STROKEAHA.106.477331
43. Siegel G Krause P Wöhrle S: Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential. Stem Cells Dev. 2012;21(13):2457-2470. 22309203 10.1089/scd.2011.0626 3425038
44. Stowe AM Adair-Kirk TL Gonzales ER: Neutrophil elastase and neurovascular injury following focal stroke and reperfusion. Neurobiol Dis. 2009;35(1):82-90. 19393318 10.1016/j.nbd.2009.04.006 2708673
45. Strong K Mathers C Bonita R: Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6(2):182-187. 17239805 10.1016/S1474-4422(07)70031-5
46. Swanson RA Morton MT Tsao-Wu G: A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10(2):290-293. 1689322 10.1038/jcbfm.1990.47
47. Thum T Bauersachs J Poole-Wilson PA: The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol. 2005;46(10):1799-1802. 16286162 10.1016/j.jacc.2005.07.053
48. Truelsen T Piechowski-Joźwiak B Bonita R: Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol. 2006;13(6):581-598. 16796582 10.1111/j.1468-1331.2006.01138.x
49. van der Weerd L Tariq Akbar M Aron Badin R: Overexpression of heat shock protein 27 reduces cortical damage after cerebral ischemia. J Cereb Blood Flow Metab. 2010;30(4):849-856. 19997117 10.1038/jcbfm.2009.249 2949174
50. Wallis C Melnick JL: Photodynamic inactivation of animal viruses: a review. Photochem Photobiol. 1965;4(2):159-170. 4956157 10.1111/j.1751-1097.1965.tb05733.x
51. Williams AR Hare JM: Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109(8):923-940. 21960725 10.1161/CIRCRESAHA.111.243147 3604746
52. Wilson BE Mochon E Boxer LM: Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol. 1996;16(10):5546-5556. 8816467 231554
53. Wollert K Drexler H: Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol. 2010;7(4):204-215. 20177405 10.1038/nrcardio.2010.1
54. Zhang Y Park TS Gidday JM: Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am J Physiol Heart Circ Physiol. 2007;292(6):H2573-81. 17337592 10.1152/ajpheart.01098.2006